Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.0K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

45
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

302
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
302

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Effects of Poly(I:C)-induced Neuroinflammation on Hippocampal Astrocyte Function and Glycolytic Metabolism.

Journal of neurochemistry·2026
Same author

Preventive Aerobic Training Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Redox Status and Attenuating Cardiac Stress-Related Signaling.

Cells·2026
Same author

Zolpidem May Affect Glial Flow in Addition to Norepinephrine-Mediated Vasomotility of the Glymphatic System.

CNS drugs·2026
Same author

Melatonin Modulates Astrocyte Inflammatory Response and Nrf2/SIRT1 Signaling Pathways in Adult Rat Cortical Cultures.

Biomedicines·2025
Same author

Resveratrol Mitigates High Glucose-Induced Inflammation in Astroglial Cells.

Metabolites·2025
Same author

Methylglyoxal, a Knot to Be Untied in Brain Glucose Hypometabolism.

Metabolites·2025
Same journal

Correction: Ncongwane et al. Labdane Diterpenoids from <i>Leonotis ocymifolia</i> with Selective Cytotoxic Activity Against HCC70 Breast Cancer Cell Line. <i>Diseases</i> 2025, <i>13</i>, 140.

Diseases (Basel, Switzerland)·2026
Same journal

Medication Adherence, Treatment Attitudes, and Beliefs About Medicines in Romanian Psychiatric Patients: A Cross-Sectional Study.

Diseases (Basel, Switzerland)·2026
Same journal

Patterns of Infectious Disease Identified in Clinical Autopsy at a South African Tertiary Care Setting: A 10-Year Retrospective Study.

Diseases (Basel, Switzerland)·2026
Same journal

Individuals with ABO Groups Show Significant Differences in Levels of Circulating Biomarkers Related to Inflammation, Apoptosis, Endothelial Dysfunction, Tissue Remodeling and Neurodegeneration: A Pilot Study.

Diseases (Basel, Switzerland)·2026
Same journal

Transcriptomic Signatures Associated with Doxorubicin Treatment in Liposarcoma Reveal Coordinated Regulatory Patterns.

Diseases (Basel, Switzerland)·2026
Same journal

Intramedullary Nailing Versus Modular Megaprosthesis in Pathological Humeral Fractures: A 10-Year Retrospective Comparative Study.

Diseases (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.

Amado Diaz de la Fe1, Alejandro Armando Peláez Suárez1, Marinet Fuentes Campos2

  • 1Neuromuscular Diseases Clinic, International Center for Neurological Restoration, Habana 11300, Cuba.

Diseases (Basel, Switzerland)
|April 30, 2021
PubMed
Summary
This summary is machine-generated.

The novel coronavirus (SARS-CoV-2) can affect the central nervous system, impacting patients with multiple sclerosis (MS). This review examines COVID-19 risks, comorbidities, and MS-specific factors like relapses and treatment.

Keywords:
COVID-19SARS-CoV-2benefit versus risk in multiple sclerosis (BRMS)multiple sclerosis (MS)

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.7K

Related Experiment Videos

Last Updated: Nov 7, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.7K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • The novel coronavirus (SARS-CoV-2) can cause severe respiratory illness with documented central nervous system (CNS) impact.
  • Neurologists are actively identifying neurological manifestations of COVID-19 and differentiating them from pre-existing neurological conditions.

Purpose of the Study:

  • To review the relationship between SARS-CoV-2 infection and multiple sclerosis (MS).
  • To assess the management of risks associated with COVID-19 in MS patients, including comorbidities.
  • To explore MS-specific factors such as relapses and treatment dosages in the context of the pandemic.

Main Methods:

  • Literature review of clinical and experimental evidence.
  • Synthesis of data on SARS-CoV-2 infection, neurological impact, and multiple sclerosis.
  • Analysis of risk factors and management strategies.

Main Results:

  • SARS-CoV-2 infection presents neurological challenges, particularly for individuals with pre-existing conditions like MS.
  • Understanding COVID-19's impact on MS requires differentiating viral effects from disease course and comorbidities.
  • Evidence suggests a need for careful management of MS patients during the pandemic, considering relapses and treatment tolerance.

Conclusions:

  • COVID-19 poses unique risks to patients with multiple sclerosis, necessitating a comprehensive understanding of its neurological and systemic effects.
  • Effective management strategies are crucial for MS patients during the pandemic to mitigate risks from infection, comorbidities, and disease activity.
  • Further research is needed to fully elucidate the long-term neurological consequences of SARS-CoV-2 in MS populations.